262 results on '"Houk, Brett A."'
Search Results
2. 8. Social-Political Manifestations of the Terminal Classic: Colha, Northern Belize, as a Case Study
3. Index
4. List of Contributors
5. 12. Lords of the Life Force and Their People: Reflections on Ritual Violence and Reverence in the Maya Archaeological Record
6. References
7. 11. Dynamic Transitions at El Perú-Waka’: Late Terminal Classic Ritual Repurposing of a Monumental Shrine
8. 6. Destruction Events and Political Truncation at the Little Kingdom of Minanha, Belize
9. 7. The Collapses in the West and the Violent Ritual Termination of the Classic Maya Capital Center of Cancuen: Causes and Consequences
10. Title Page, Copyright, Dedication
11. 9. Signs of the Times: Terminal Classic Surface Deposits and the Fates of Maya Kingdoms in Northwestern Belize
12. 5. The Life and Afterlife of the Classic Period Piedras Negras Kingdom
13. Foreword
14. 3. Killing the “Kings of Stone': The Defacement of Classic Maya Monuments
15. 10. Events and Processes Leading to the Abandonment of the Maya City of Blue Creek, Belize
16. 2. Cross-Cultural Perspectives on the Scapegoat King: The Anatomy of a Model
17. 4. Concepts of Legitimacy and Social Dynamics: Termination Ritual and the Last King of Aguateca, Guatemala
18. List of Tables
19. 1. Introduction
20. Cover
21. List of Figures
22. Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC
23. Impact of Sotorasib on the Pharmacokinetics and Pharmacodynamics of Metformin, a MATE1/2K Substrate, in Healthy Subjects
24. Absorption, metabolism and excretion of [14C]-sotorasib in healthy male subjects: characterization of metabolites and a minor albumin-sotorasib conjugate
25. KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
26. Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib.
27. Functional diversity of microbial ecologies estimated from ancient human coprolites and dental calculus
28. A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer
29. Power and Politics on the Late Colonial Frontier of British Honduras
30. Kaxil Uinic: Archaeology at a San Pedro Maya Village in Belize
31. The Strange Bedfellows of Northern Belize: British Colonialists, Confederate Dreamers, Creole Loggers, and the Caste War Maya of the Late Nineteenth Century
32. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
33. How the Maya Shaped Their World
34. All the World’s a Stage
35. All the World’s a Stage
36. How the Maya Shaped Their World
37. Standard Error of Empirical Bayes Estimate in NONMEM® VI.
38. Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp alfa, a Bispecific Inhibitor of BAFF and ICOSL : Analyses of Phase 1 Clinical Trials
39. Abstract CT264: Taking sotorasib with an acidic beverage improves sotorasib exposure for subjects on omeprazole
40. Ancient Maya Cities of the Eastern Lowlands
41. Supplemental Table 1 from First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer
42. Supplemental Table 6 from First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer
43. Supplemental Table 4 from First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer
44. Supplementary Methods, Figures 1-3, Tables 1-5 from A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas
45. COMMUNITY, AUTHORITY, AND SPACE IN THE HEART OF LA MILPA
46. A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer
47. Kaxil Uinic: Archaeology at a San Pedro Maya Village in Belize
48. Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL: Analyses of Phase I Clinical Trials.
49. Impact of Sotorasib on the Pharmacokinetics and Pharmacodynamics of Metformin, a MATE1/2K Substrate, in Healthy Subjects
50. Ancient Lowland Maya neighborhoods: Average Nearest Neighbor analysis and kernel density models, environments, and urban scale
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.